MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. We will begin the MacroGenics 2023 Fourth Quarter Corporate Progress and Financial Results Conference Call in just a moment.
Macrogenics Inc (MGNX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 4,572,000 | $43,982,640 | -3% | 0.6% |
| 2. | RA Capital Management Peter Kolchinsky | 4,053,077 | $38,990,601 | +1086% | 0.6% |
| 3. | SilverArc Capital Devesh Gandhi | 1,258,641 | $12,108,126 | -1% | 3.6% |
| 4. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 1,178,796 | $11,340,018 | 0.27% | |
| 5. | Millennium Management Israel Englander | 862,965 | $8,301,723 | -58% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.46 | 150,000 | Large Shareholder | 9,929,963 | 2023-10-02 | Filing | |
| $5.26 | 200,000 | Large Shareholder | 9,779,963 | 2023-09-07 | Filing | |
| $4.91 | 15,000 | Director | 33,074 | 2023-08-30 | Filing | |
| $5.07 | 500,000 | Large Shareholder | 9,579,963 | 2023-02-14 | Filing | |
| $5.30 | 150,000 | Large Shareholder | 9,079,963 | 2023-01-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.22 | 3,165 | Officer | 0 | 2024-04-04 | Filing | |
| $17.74 | 5,351 | Officer | 3,165 | 2024-04-04 | Filing | |
| $16.38 | 232 | Officer | 8,516 | 2024-04-04 | Filing | |
| $15.51 | 147 | Officer | 8,748 | 2024-04-04 | Filing | |
| $15.07 | 42,500 | Officer | 8,895 | 2024-04-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,953,313 | $95,750,871 | 1.46% | |
| 2. | 6,140,349 | $59,070,158 | 0% | |
| 3. | 4,309,394 | $41,456,370 | 0% | |
| 4. | 2,401,704 | $23,104,392 | 1.23% | |
| 5. | 2,174,022 | $20,914,092 | 0% |
News See All
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds.
MacroGenics, Inc. (NASDAQ:MGNX) Q3 2023 Earnings Call Transcript
Operator: Good afternoon. We will begin the MacroGenics 2023 Third Quarter Corporate Progress and Financial Results Conference Call in just a moment.
MacroGenics, Inc. (NASDAQ:MGNX) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. We will begin the MacroGenics 2023 Second Quarter Corporate Progress and Financial Results Conference Call in just a moment.
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. We will begin the MacroGenics 2023 First Quarter Corporate Progress and Financial Results Conference Call in just a moment.
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. We will begin the MacroGenics 2022 Fourth Quarter Corporate Progress and Financial Results Conference Call in just a moment.
MacroGenics Inc (MGNX): Hedge Funds Taking Some Chips Off The Table
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Hedge Funds Are Cashing Out Of MacroGenics Inc (MGNX)
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of June 30th...
Should You Consider Selling Your MacroGenics (MGNX) Shares?
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Have Never Been This Bullish On MacroGenics Inc (MGNX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Billionaire Hedge Funds
